In June 2026, the Organisation for Economic Co-operation and Development (OECD) published Developments in Delegations on the Safety of Manufactured Nanomaterials and Advanced Materials – Tour de Table, a report of the Chemicals and Biotechnology Committee summarizing safety and regulatory developments between July 2024 and June 2025.‍‍ ‍

The US bioeconomy (biotechnology-based economic activity) currently contributes 5.1 percent or more of US GDP and has tremendous growth potential. Realizing that potential requires, among other efforts, investment by the government to advance innovation infrastructure including regulatory frameworks that are open to new technologies and don’t obstruct them.